Computer turns detective in the hunt for novel pathogens

A computational technique that finds foreign gene sequences in human tissues could identify pathogens that cause chronic diseases.

Written byVicki Glaser
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ALLENTOWN, PA — The potential for rapid discovery of new, disease-causing microbes, is on the horizon with successful results from a study with a new computerized technique — computational subtraction — that uses DNA matching to isolate and identify microbial gene sequences.

Computational subtraction is an in silico approach that takes advantage of the nearly completed DNA sequence of the human genome, made available through the Human Genome Project. By subtracting out the full complement of human DNA sequences from DNA libraries derived from human tissues, researchers at the Dana-Farber Cancer Institute and Harvard Medical School found they were left with a small number of DNA sequences, presumably of nonhuman origin. They could then search these sequences for evidence of microbial genes, and establish possible links between previously unknown organisms and human disease.

Senior author Matthew Meyerson and colleagues described the computational subtraction method — and how they used it ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies